BAHGAT ABDELAZIZ: Open Payments
NPI 1356394761 · AUBURN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 18 payments from 9 companies in 2025. Trend: 2023 $1,016 · 2024 $595 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $92 |
| ABBVIE INC. | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $57 |
| Dendreon Pharmaceuticals LLC | 2 | $43 |
| 180 Medical, Inc. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $35 |
| Endo USA, Inc. | 1 | $26 |
| Myriad Genetic Laboratories, Inc. | 1 | $23 |
| Medtronic, Inc. | 1 | $20 |
Products named: GEMTESA, BOTOX, Nubeqa, PROVENGE, PLUVICTO, AVEED, PROLARIS, GENTLECATH GLIDE.
Industry payments across NY — which companies pay providers there.
